Brian Jahns - Net Worth and Insider Trading
Brian Jahns Net Worth
The estimated net worth of Brian Jahns is at least $10,000 dollars as of 2024-09-21. Brian Jahns is the Senior Officer of Entheon Biomedical Corp and owns about 100,000 shares of Entheon Biomedical Corp (XCNQ:ENBI) stock worth over $10,000. Details can be seen in Brian Jahns's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian Jahns has not made any transactions after 2022-01-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brian Jahns
Brian Jahns Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brian Jahns owns 1 companies in total, including Entheon Biomedical Corp (XCNQ:ENBI) .
Click here to see the complete history of Brian Jahns’s form 4 insider trades.
Insider Ownership Summary of Brian Jahns
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XCNQ:ENBI | Entheon Biomedical Corp | 2022-01-19 | Senior Officer |
Brian Jahns Latest Holdings Summary
Brian Jahns currently owns a total of 1 stock. Brian Jahns owns 100,000 shares of Entheon Biomedical Corp (XCNQ:ENBI) as of January 19, 2022, with a value of $10,000.
Latest Holdings of Brian Jahns
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XCNQ:ENBI | Entheon Biomedical Corp | 2022-01-19 | 100,000 | 0.10 | 10,000 |
Holding Weightings of Brian Jahns
Brian Jahns Form 4 Trading Tracker
According to the SEC Form 4 filings, Brian Jahns has made a total of 6 transactions in Entheon Biomedical Corp (XCNQ:ENBI) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Entheon Biomedical Corp is the acquisition of 20,000 shares on January 19, 2022, which cost Brian Jahns around $48,000.
Insider Trading History of Brian Jahns
- 1
Brian Jahns Trading Performance
GuruFocus tracks the stock performance after each of Brian Jahns's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian Jahns is -39.88%. GuruFocus also compares Brian Jahns's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian Jahns within 3 months outperforms 0 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Brian Jahns's insider trading performs compared to the benchmark.
Performance of Brian Jahns
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.5 | | | | | |
| Relative Return to S&P 500(%) | -6.02 | | | | | |
Brian Jahns Ownership Network
Brian Jahns Owned Company Details
What does Entheon Biomedical Corp do?
Who are the key executives at Entheon Biomedical Corp?
Brian Jahns is the Senior Officer of Entheon Biomedical Corp.
Entheon Biomedical Corp (XCNQ:ENBI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Entheon Biomedical Corp (XCNQ:ENBI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Entheon Biomedical Corp (XCNQ:ENBI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Entheon Biomedical Corp (XCNQ:ENBI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Entheon Biomedical Corp Insider Transactions
Brian Jahns Mailing Address
Above is the net worth, insider trading, and ownership report for Brian Jahns. Currently GuruFocus does not have mailing address information for Brian Jahns.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
